Colon cancer is one of the most common malignancies worldwide and remains a major focus of oncology research.

Despite significant advances in screening and treatment, many patients are still diagnosed after the disease has progressed beyond the earliest stages.

Researchers continue to investigate the genetic, molecular, and immunological mechanisms that drive tumor development to improve early detection and develop more effective therapies.

High-quality Colon Cancer Samples play a vital role in these efforts.

Bay Biosciences provides well-characterized clinical biospecimens, including Colon Tumor Tissue Samples, serum, plasma, peripheral blood mononuclear cells (PBMCs), etc.

These Oncology Biospecimens support biomarker discovery, drug development, diagnostic research, and precision medicine.

Colon cancer samples

Understanding Colon Cancer

Colon cancer develops when abnormal cells grow uncontrollably within the colon, which forms the longest portion of the large intestine.

The disease usually begins as small, noncancerous growths called polyps.

Over time, certain polyps may accumulate additional genetic mutations and develop into cancer.

Colon cancer and rectal cancer are often grouped as colorectal cancer because they affect different parts of the large intestine and share many biological characteristics.

Consequently, researchers frequently study Colorectal Cancer Samples to better understand disease progression across both anatomical sites.

Although colon cancer most commonly affects older adults, the number of younger patients diagnosed with the disease has increased in recent years.

Early detection through screening significantly improves treatment outcomes because many tumors develop slowly before causing noticeable symptoms.

Symptoms of Colon Cancer

Many patients experience few or no symptoms during the early stages of colon cancer. As the tumor grows, symptoms gradually become more noticeable.

Common symptoms include:

Advanced disease may produce additional symptoms if cancer spreads to organs such as the liver or lungs.

Causes of Colon Cancer

The exact cause of colon cancer remains unknown.

However, researchers understand that the disease develops after genetic alterations disrupt the normal regulation of cell growth and division.

Healthy cells divide, mature, and eventually die through a carefully controlled process.

Mutations affecting oncogenes and tumor suppressor genes interfere with this process, allowing abnormal cells to continue multiplying and forming tumors.

Most colon cancers develop from adenomatous polyps that gradually become malignant over several years.

Cancer cells may eventually invade nearby tissues and spread through the bloodstream or lymphatic system to distant organs in a process known as metastasis.

Risk Factors for Colon Cancer

Several factors increase an individual’s likelihood of developing colon cancer.

Age

Increasing age remains one of the strongest risk factors. Although younger adults can develop colon cancer, the disease occurs more frequently after age 50.

Family History and Genetics

Individuals with a family history of colon cancer or inherited genetic syndromes have a higher lifetime risk.

Colon Polyps

Certain adenomatous polyps have the potential to develop into cancer if they remain untreated.

Inflammatory Bowel Disease

Long-standing inflammatory bowel diseases, including ulcerative colitis and Crohn’s disease, increase the risk of developing colon cancer.

Lifestyle Factors

Several lifestyle factors have been associated with increased risk, including:

Diagnosis of Colon Cancer

The diagnosis of colon cancer begins with a complete medical history, physical examination, and evaluation of symptoms.

Healthcare providers may perform several diagnostic procedures to confirm the diagnosis and determine the stage of disease.

Firstly, colonoscopy remains the gold standard for detecting colon cancer. It allows physicians to examine the entire colon, identify suspicious lesions, remove polyps, and obtain biopsy specimens.

Secondly, tissue biopsy confirms the diagnosis. Pathologists examine the collected tissue under a microscope to identify cancer cells and determine tumor characteristics.

Thirdly, imaging studies help evaluate the extent of disease. These may include CT scans, MRI, PET scans, chest X-rays, or abdominal ultrasound to determine whether cancer has spread.

Finally, laboratory testing and molecular profiling provide additional clinical information that may guide treatment decisions, including genetic testing for specific biomarkers associated with targeted therapies.

Treatment of Colon Cancer

Treatment depends on the stage of disease, tumor location, overall health, and individual patient factors.

Surgery

Surgeons remove the affected portion of the colon along with nearby lymph nodes to reduce the risk of recurrence.

Chemotherapy

Chemotherapy uses medications that destroy rapidly dividing cancer cells. It may be administered before surgery to shrink tumors or after surgery to eliminate remaining cancer cells.

Radiation Therapy

Although radiation therapy is more commonly used for rectal cancer, selected colon cancer patients may receive radiation when tumors involve nearby structures or metastatic disease.

Targeted Therapy

Targeted therapies interfere with specific molecular pathways that promote cancer growth. These treatments are often guided by genetic testing of tumor tissue.

Immunotherapy

Certain patients whose tumors demonstrate microsatellite instability (MSI-H) or mismatch repair deficiency (dMMR) may benefit from immunotherapy, which helps the immune system recognize and attack cancer cells.

The Role of Colon Cancer Samples in Research

High-quality Colon Cancer Samples are essential for advancing cancer research and improving patient outcomes.

Firstly, researchers use Colon Tumor Tissue Samples to investigate the genetic and molecular mechanisms responsible for tumor initiation and progression.

Secondly, Human Tumor Tissue Samples support biomarker discovery, allowing scientists to identify new diagnostic and prognostic markers.

Thirdly, Fresh Frozen Tissue Samples preserve DNA, RNA, and proteins with minimal degradation, making them valuable for genomic, transcriptomic, and proteomic studies.

Moreover, Human Cancer Tissue Samples help evaluate treatment response, investigate mechanisms of drug resistance, and support precision oncology research.

Finally, comprehensive Oncology Biospecimens, including matched serum, plasma, PBMCs, and tissue specimens, enable investigators to study circulating biomarkers alongside tumor biology, accelerating drug discovery and personalized medicine.

Supporting Your Research with Bay Biosciences

Bay Biosciences provides high-quality, fully characterized Colon Cancer Samples collected under rigorous clinical and ethical standards.

Our comprehensive range of biospecimens includes:

If you have any questions, concerns, or special requests, please don’t hesitate to contact us.